# US 2024/0189475 A1 · Nanofibrous scaffold comprising usnic acid for skin tissue regeneration

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2024/0189475 A1
- Document ID: US20240189475A1
- Status: Published application
- Kind: A1
- Application number: 18/316,623
- Filed: 2023-05-12
- Published: 2024-06-13
- Earliest claimed: 2022-12-13
- Assignees: Pukyong National University Industry-University Cooperation Foundation
- Applicants: Pukyong National University Industry-University Cooperation Foundation
- Inventors: Won-Kyo Jung; Milan Pathum Chandika; Tae-Hee Kim; Se-Chang Kim
- Web page: https://patentgrep.com/patent/US20240189475A1

## CPC

- A61L 15/26: Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds; Derivatives thereof {(A61L15/225 takes precedence)}
- A61L 15/40: containing ingredients of undetermined constitution or reaction products thereof {, e.g. plant or animal extracts}
- A61L 15/42: Use of materials characterised by their function or physical properties (liquid bandages A61L26/00)
- A61L 27/18: obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds
- A61L 27/3633: {Extracellular matrix [ECM]}
- A61L 27/50: Materials characterised by their function or physical properties {, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials}
- A61L 27/56: Porous materials, {e.g. foams or sponges}
- A61L 2400/12: Nanosized materials, e.g. nanofibres, nanoparticles, nanowires, nanotubes; Nanostructured surfaces
- B82Y 5/00: Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
- B82Y 30/00: Nanotechnology for materials or surface science, e.g. nanocomposites
- B82Y 40/00: Manufacture or treatment of nanostructures
- A61L: METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES (preservation of bodies or disinfecting characterised by the agents employed A01N; preserving, e.g. sterilising, food or foodstuffs A23; preparations for medical, dental or toiletry purposes A61K)
- B82Y: SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES

## Abstract

An example embodiment of the present disclosure relates to a nanofiber scaffold including polycaprolactone (poly(ε-caprolactone; PCL), decellularized extracellular matrix (dECM) and usnic acid (UA), and a preparation method thereof. The nanofiber scaffold of an example embodiment of the present disclosure has a uniform nanofiber structure, good fluid absorption and retention, moderate release rate, high mechanical stability, thermal stability, and semi-crystalline structure, and exhibits excellent antibacterial efficacy against fungi/bacteria such as Candida albicans, and good compatibility with human-derived fibroblasts.

## Claims

### Claim 1

A nanofiber scaffold comprising:
polycaprolactone (poly(ε-caprolactone; PCL);
decellularized extracellular matrix (dECM); and
usnic acid (UA).

### Claim 2 (depends on 1)

The nanofiber scaffold of claim 1, wherein the nanofiber scaffold is prepared by electrospinning.

### Claim 3 (depends on 1)

The nanofiber scaffold of claim 1, wherein the nanofiber scaffold includes the polycaprolactone and the decellularized extracellular matrix in a weight ratio of 8 to 2:2 to 8.

### Claim 4 (depends on 1)

The nanofiber scaffold according to claim 1, wherein the nanofiber scaffold is cross-linked.

### Claim 5

A method of preparing a nanofiber scaffold, the method compising:
mixing polycaprolactone, decellularized extracellular matrix, and usnic acid (phase 1);
preparing a nanofiber mat by electrospinning the mixture (phase 2);
cross-linking the nanofiber mat (phase 3); and
freeze-drying the cross-linked nanofiber mat (phase 4).

### Claim 6 (depends on 5)

The method of claim 5, wherein, in phase 1, the polycaprolactone and the decellularized extracellular matrix are mixed in a weight ratio of 8 to 2:2 to 8.

### Claim 7 (depends on 5)

The method of claim 5, wherein, in phase 3, the nanofiber mat is impregnated with EDC and NHS in ethanol and cross-linked.

### Claim 8 (depends on 1)

A wound dressing comprising the nanofiber scaffold according to claim 1.

### Claim 9 (depends on 2)

A wound dressing comprising the nanofiber scaffold according to claim 2.

### Claim 10 (depends on 3)

A wound dressing comprising the nanofiber scaffold according to claim 3.

### Claim 11 (depends on 4)

A wound dressing comprising the nanofiber scaffold according to claim 4.
